SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:July 2, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:July 2, 2021Completed
Condition(s):Non-Small-Cell Lung CarcinomaLast Updated:February 5, 2018Unknown status
Condition(s):Ischemic Heart FailureLast Updated:August 18, 2017Unknown status
Condition(s):Type 2 Diabetes Mellitus; Chronic Liver DiseaseLast Updated:April 18, 2011Unknown status
Condition(s):Liver CirrhosisLast Updated:September 7, 2015Completed
Condition(s):Liver CirrhosisLast Updated:October 18, 2012Terminated
Condition(s):Schistosoma MansoniLast Updated:July 12, 2022Completed
Condition(s):Hemiplegia; Motor Activity; Physical ActivityLast Updated:April 3, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.